#longevity medicine
Discover 5 curated intelligence briefings related to this specific topic.
Life Is Now A Programmable Commodity
The creation of SpudCell and the rise of regional CDMOs in Poland and Nigeria signal a new era where biological life is treated as an industrial input rather than a mystery.
Why Oncology Infrastructure is Outpacing Drug Discovery
Three ADC approvals in five days and massive capacity expansions in Switzerland signal a brutal transition: the biotech industry is no longer just hunting for cures, it is scaling the factories to deliver them.
The $50 Prescription and the Protein Shortage
As Medicare launches a pilot program to slash GLP-1 costs for millions, the immediate fallout is hitting unexpected sectors: the dairy industry is struggling to meet a protein surge, and employers are scrambling to rewrite their healthcare budgets.
Is Biological Age the New Metric of Survival?
From the discovery of accelerated aging in younger generations to Roche's aggressive move into gene sequencing, the last week of June 2026 has redefined the window for medical intervention.
The Human Upgrade: Biohacking's Pivot from Luxury to Clinical Reality
From Bangkok's high-tech longevity hubs to the clinical application of CRISPR, June 2026 marks a systemic shift in how we approach the human body—moving from reactive healthcare to aggressive optimization.